T-cell-directed/JJ
TAL-1/NN
expression/NN
induces/VBZ
T-cell/NN
malignancies/NNS
in/IN
transgenic/JJ
mice/NNS
./.

The/DT
TAL-1/NN
gene/NN
specifies/VBZ
for/IN
a/DT
basic/JJ
domain-helix-loop-helix/JJ
protein/NN
,/,
which/WDT
is/VBZ
involved/VBN
in/IN
the/DT
control/NN
of/IN
normal/JJ
hematopoiesis/NN
./.
=====
In/IN
human/JJ
pathology/NN
,/,
the/DT
TAL-1/NN
gene/NN
product/NN
is/VBZ
expressed/VBN
in/IN
a/DT
high/JJ
percentage/NN
of/IN
T-cell/NN
acute/JJ
lymphoblastic/JJ
leukemias/NNS
in/IN
the/DT
pediatric/JJ
age/NN
range/NN
;/:
however/RB
,/,
it/PRP
has/VBZ
not/RB
been/VBN
established/VBN
whether/IN
the/DT
expression/NN
has/VBZ
a/DT
causal/JJ
role/NN
in/IN
oncogenesis/NN
./.
=====
In/IN
this/DT
report/NN
,/,
we/PRP
describe/VBP
the/DT
phenotype/NN
of/IN
mouse/NN
transgenic/JJ
lines/NNS
obtained/VBN
by/IN
inducing/VBG
tal-1/NN
protein/NN
expression/NN
in/IN
lymphoid/JJ
tissues/NNS
using/VBG
the/DT
LCK/NN
promoter/NN
./.
=====
The/DT
survival/NN
rate/NN
of/IN
tal-1/NN
transgenic/JJ
animals/NNS
was/VBD
much/RB
lower/JJR
as/IN
compared/VBN
with/IN
control/NN
mice/NNS
./.
=====
Histopathological/JJ
analysis/NN
revealed/VBD
lymphomas/NNS
of/IN
T-cell/NN
type/NN
,/,
often/RB
comprising/VBG
a/DT
minor/JJ
B-cell/NN
component/NN
./.
=====
Some/DT
mice/NNS
showed/VBD
marked/JJ
splenic/JJ
lymphocyte/NN
depletion/NN
./.
=====
Primary/JJ
lymphocyte/NN
cultures/NNS
showed/VBD
partial/JJ
independence/NN
from/IN
exogenous/JJ
growth/NN
stimuli/NNS
and/CC
increased/VBD
resistance/NN
to/TO
low-serum/JJ
apoptosis/NN
./.
=====
To/TO
further/RB
unravel/VB
the/DT
tal-1/NN
oncogenic/JJ
potential/NN
,/,
a/DT
strain/NN
of/IN
tal-1/NN
transgenic/JJ
mice/NNS
was/VBD
crossbred/VBN
with/IN
p53-/-/JJ
mice/NNS
;/:
the/DT
survival/NN
rate/NN
in/IN
these/DT
animals/NNS
was/VBD
reduced/VBN
by/IN
more/JJR
than/IN
one-half/NN
when/WRB
compared/VBN
with/IN
that/DT
of/IN
tal-1/NN
mice/NNS
,/,
and/CC
histopathological/JJ
analysis/NN
revealed/VBD
exclusively/RB
T-cell/NN
lymphomas/NNS
./.
=====
These/DT
data/NNS
indicate/VBP
that/IN
TAL-1/NN
,/,
expressed/VBN
in/IN
T/NN
cells/NNS
,/,
is/VBZ
per/FW
se/FW
a/DT
potent/JJ
oncogene/NN
,/,
which/WDT
may/MD
exert/VB
a/DT
key/JJ
leukemogenetic/JJ
role/NN
in/IN
the/DT
majority/NN
of/IN
T-cell/NN
acute/JJ
lymphoblastic/JJ
leukemias/NNS
./.